Tarasenko, N.; Wilner, H.J.; Nudelman, A.; Kessler-Icekson, G.; Rephaeli, A.
Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer. Pharmaceuticals 2021, 14, 1244.
https://doi.org/10.3390/ph14121244
AMA Style
Tarasenko N, Wilner HJ, Nudelman A, Kessler-Icekson G, Rephaeli A.
Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer. Pharmaceuticals. 2021; 14(12):1244.
https://doi.org/10.3390/ph14121244
Chicago/Turabian Style
Tarasenko, Nataly, Harel Josef Wilner, Abraham Nudelman, Gania Kessler-Icekson, and Ada Rephaeli.
2021. "Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer" Pharmaceuticals 14, no. 12: 1244.
https://doi.org/10.3390/ph14121244
APA Style
Tarasenko, N., Wilner, H. J., Nudelman, A., Kessler-Icekson, G., & Rephaeli, A.
(2021). Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer. Pharmaceuticals, 14(12), 1244.
https://doi.org/10.3390/ph14121244